<< Athersys, Inc. (NASDAQ:ATHX) Worth an Investment?
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more. Neither Zacks Investment Information Providers, or gathered by Zacks Investment Research, Inc. from Investment Research, Inc, licensed by Zacks Investment Research, Inc. from Each of the company logos represented herein are trademarks of Verizon Media; Microsoft Corporation; Nasdaq, Inc.; Dow Jones & Company; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. The Zacks Rank has been called the Billion Dollar Secret. There may be delays, omissions, or inaccuracies This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. Stock Analysis Report. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. Plus, ATHX info will be updated daily in your Zacks.com Portfolio Tracker . Historical Performance In The News: Taking a look at the performance of Athersys, Inc. stock, an investor will come to know that the weekly performance for this stock is valued at -14.88%, resulting in a performance for the month at -14.88%. In fact, when combining a Zacks Rank #3 or better and a positive Earnings ESP, stocks produced a positive surprise 70% of the time, while they also saw 28.3% annual returns on average, according to our 10 year backtest. Webull Financial LLC is a member of The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.The technique has proven to be very useful for finding positive surprises. According to TipRanks.com, Messer is a 4-star analyst with an average return of 9.7% and a 46.4% success rate. Its clinical development programs are focused primarily on treating critical care indications neurological conditions, cardiovascular diseases, inflammatory and immune disorders, pulmonary and other conditions. Zacks Ranks stocks can, and often do, change throughout the month. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. This includes personalizing content and advertising. . The monthly returns are then compounded to arrive at the annual return. LOG IN. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.33% per year. MARKETS. To learn more, You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. How good is it? The company's lead platform product is MultiStem cell therapy, an off the shelf allogeneic stem cell product currently in Phase 3 clinical development for treating ischemic stroke. ATHX--0.00%--Athersys to Host Second Quarter Financial Results Call. Feb 18, 2016 1:06 PM EST. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations.Real time prices by BATS. Add to Portfolio Compare. SIGN UP. The sector with the worst average Zacks Rank (16 out of 16) would place in the bottom 1%.Zacks Earnings ESP (Expected Surprise Prediction) looks to find companies that have recently seen positive earnings estimate revision activity. ZacksTrade and Zacks.com are separate companies. This is a 66.67 percent decrease over losses of $(0.06) per share from the sameAthersys to Host Second Quarter Financial Results CallAthersys, Inc. (Nasdaq: ATHX) will release its second quarter 2020 financial results on Monday, August 10, 2020.Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.10% to $303.98.